drugset / Trial / NCT06141889
Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This study is a single-dose, open-label, randomized crossover and multiple-dose, open-label study to evaluate the PK of azelaprag in older adult healthy volunteers.
Timeline
- Start
- 2023-11-17
- Primary completion
- 2024-01-26
- Completion
- 2024-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azelaprag | Small molecule | — | Oral |
Indications
No indication recorded.